Third-generation cephalosporins: a review of new board spectrum antibiotics.
D000617:Aminoglycosides / Q000494:pharmacology; D002511:Cephalosporins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced; D006801:Humans; D008826:Microbial Sensitivity Tests
D000617:Aminoglycosides; D002511:Cephalosporins